Healthcare Performance Scorecard

Healthcare Performance Scorecard

If one judges by statistics and performance scorecards alone, in the United States, healthcare means high cost and low quality.

The expenditures are enormous. Healthcare spending in the United States accounts for around 17 percent of gross domestic product (GDP), and the U.S. has the world’s largest. Other advanced countries spend between 9 and 11 percent of their considerably smaller GDPs. Historically, U.S. healthcare spending has grown faster than in other advanced countries. From 1980 until 2020, healthcare cost as a percentage of GDP doubled, but in other countries, it went up by only 2 percent. Healthcare has been a growth industry, so to speak.

Doctor compensation is uneven, and in the United States, there are some very wealthy doctors. The top 1 percent make $4.1 million per year. The top 25 percent make $871,000. The average, however, is $350,000, which is less than many computer programmers or social media workers. In high-tax states, when income and property tax are combined, $350,000 does not get very far, because the tax rate is more than one-half. So, except for a very few MDs, going into medicine is not a path to wealth. We must assume that the primary motivation at the heart of many medical personnel is altruistic humanism.

In addition, U.S. doctors have significant expenses not found in some other countries. For example, they pay big for malpractice insurance. For many, premiums range from $4,000 to $12,000 per year. But surgeons may pay $50,000 and OB-GYNS may pay more than $200,000 per year.

These incredible costs, which appear to be a phenomenon found only in the United States, have their etiology in the exorbitant litigation nightmare. In legal circles, malpractice litigation and product liability are major “industries,” and juries can be counted on to award very substantial damages.

When a number of benchmark measurements are taken into account, we see that out of 11 advanced countries – Australia, Canada, France, Germany, the Netherlands, New Zealand, Norway, Sweden, Switzerland, and the United Kingdom – U.S. healthcare is in last place, according to the Commonwealth Fund, which examined dozens of variables to make its assessment. 

By many crucial measures, the United States gets very poor scores. It is lowest in access to care, lowest in administrative efficiency, lowest in equity, and lowest in healthcare outcomes. Also, the gap between the U.S. and other nations is significant.

It may surprise some that the U.S. ranks very low on the ability of citizens to get same-day care or after-hours care.

Health Insurance

The United States is the only high-income country with no universal health insurance. Thirty million are uninsured; 40 million are chronically under-insured. The U.S. has the second-highest out-of-pocket expenses.

The system of private health insurance in the United States often receives acidic criticism. “Gotcha” health insurance rules surprise patients with a much higher level of claim rejection, and this often is found out after the cost has been incurred, so consequently it is passed to the patient. This is the precise opposite of what insurance is designed to do. Repeatedly, U.S. doctors have more problems getting medication or treatment for their patients, because insurance does not allow them to. This “pre-authorization” process causes major problems. Often well-known and effective off-label treatments are turned down because the insurance carrier will only approve what the Food and Drug Administration (FDA) certifies.

Medical Bureaucracy

The management of healthcare claims and payments in the U.S. is another major headache. In comparison to other countries, U.S. citizens spend the most time doing healthcare-related paperwork. The U.S. is the only country in the world that employs an army of paid specialists to help citizens navigate the medical bureaucracy. Often, legal counsel is required, particularly when appeals against coverage are involved.

If equity is measured by how good healthcare is for a patient, depending on how rich they are, then the U.S. is by far the worst. Even its higher-income citizens have access problems equivalent to the least wealthy in the second-worst country (New Zealand). The breakdown of immigration may lead to further change. With the flood of 8 million or so non-citizens who have entered the country, once they are provided government-funded healthcare and put in the statistics, the equity picture will be much worse.

Patient Outcomes

The overall results are not stellar. Far from it. In the U.S., relatively more people have a “negative patient outcome” – that is, they die. Mortality is 250 per 100,000. The next-highest country is only around 150. Switzerland is 125 – one-half of the U.S. number. Public health also has a mixed track record. For example, U.S. COVID deaths were higher than in Nigeria, which had no national vaccination program.

The Bright Side

It is not all negative. Far from it. The U.S. has relatively high influenza vaccination rates. Its record on surgery is excellent. For example, U.S. patients experience lower rates of postoperative sepsis after abdominal surgery.

It is not an exaggeration to say that the U.S. leads the world in medical innovation. The high costs are part of the costs of that investment. High prices for pharmaceuticals finance the research and development (R&D) needed to develop new cures.

The U.S. also probably has deployed on average the most advanced medical information systems in the world. For example, the incredible investments made in computerization result in superior e-Methods for filling prescriptions. The U.S. excels in keeping track of details.

All services given to a patient, everyone involved, how much time was spent, what observations were made, the 24-7 monitoring telemetry of the patient’s condition, visitor logs, to name only a few factors. We count and measure almost everything that happens to a patient. This ocean of data will form the foundation for application of artificial intelligence to allow for big data-mining and other innovations.

In sum, the seemingly excessive expenditures on information technology are setting the stage for the evolution of smart hospitals, and ultimately, better healthcare.

The U.S. healthcare system is evolving at its own pace. It is complex, and designed to accommodate a wide range of cultural, economic, business, and political interests. It is set up to pour a significant amount of cash into investments for R&D and innovation. It could be that Americans are spending more because they are investing more and innovating more. After all, mere statistics never give the entire story. Nevertheless, if we go by the statistics and benchmarks alone, the U.S. is far from getting its money’s worth.

As many Europeans say: “the Americans always get it right, but only after trying every other option.”

Facebook
Twitter
LinkedIn

Edward M. Roche, PhD, JD

Edward Roche is the director of scientific intelligence for Barraclough NY, LLC. Mr. Roche is also a member of the California Bar. Prior to his career in health law, he served as the chief research officer of the Gartner Group, a leading ICT advisory firm. He was chief scientist of the Concours Group, both leading IT consulting and research organizations. Mr. Roche is a member of the RACmonitor editorial board as an investigative reporter and is a popular panelist on Monitor Mondays.

Related Stories

Leave a Reply

Please log in to your account to comment on this article.

Featured Webcasts

2026 IPPS Masterclass 3: Master MS-DRG Shifts and NTAPs

2026 IPPS Masterclass Day 3: MS-DRG Shifts and NTAPs

This third session in our 2026 IPPS Masterclass will feature a review of FY26 changes to the MS-DRG methodology and new technology add-on payments (NTAPs), presented by nationally recognized ICD-10 coding expert Christine Geiger, MA, RHIA, CCS, CRC, with bonus insights and analysis from Dr. James Kennedy.

August 14, 2025
2026 IPPS Masterclass Day 2: Master ICD-10-PCS Changes

2026 IPPS Masterclass Day 2: Master ICD-10-PCS Changes

This second session in our 2026 IPPS Masterclass will feature a review the FY26 changes to ICD-10-PCS codes. This information will be presented by nationally recognized ICD-10 coding expert Christine Geiger, MA, RHIA, CCS, CRC, with bonus insights and analysis from Dr. James Kennedy.

August 13, 2025
2026 IPPS Masterclass 1: Master ICD-10-CM Changes

2026 IPPS Masterclass Day 1: Master ICD-10-CM Changes

This first session in our 2026 IPPS Masterclass will feature an in-depth explanation of FY26 changes to ICD-10-CM codes and guidelines, CCs/MCCs, and revisions to the MCE, presented by presented by nationally recognized ICD-10 coding expert Christine Geiger, MA, RHIA, CCS, CRC, with bonus insights and analysis from Dr. James Kennedy.

August 12, 2025

Trending News

Featured Webcasts

The Two-Midnight Rule: New Challenges, Proven Strategies

The Two-Midnight Rule: New Challenges, Proven Strategies

RACmonitor is proud to welcome back Dr. Ronald Hirsch, one of his most requested webcasts. In this highly anticipated session, Dr. Hirsch will break down the complex Two Midnight Rule Medicare regulations, translating them into clear, actionable guidance. He’ll walk you through the basics of the rule, offer expert interpretation, and apply the rule to real-world clinical scenarios—so you leave with greater clarity, confidence, and the tools to ensure compliance.

June 19, 2025
Open Door Forum Webcast Series

Open Door Forum Webcast Series

Bring your questions and join the conversation during this open forum series, live every Wednesday at 10 a.m. EST from June 11–July 30. Hosted by Chuck Buck, these fast-paced 30-minute sessions connect you directly with top healthcare experts tackling today’s most urgent compliance and policy issues.

June 11, 2025
Open Door Forum: The Changing Face of Addiction: Coding, Compliance & Care

Open Door Forum: The Changing Face of Addiction: Coding, Compliance & Care

Substance abuse is everywhere. It’s a complicated diagnosis with wide-ranging implications well beyond acute care. The face of addiction continues to change so it’s important to remember not just the addict but the spectrum of extended victims and the other social determinants and legal ramifications. Join John K. Hall, MD, JD, MBA, FCLM, FRCPC, for a critical Q&A on navigating substance abuse in 2025.  Register today and be a part of the conversation!

July 16, 2025

Trending News

Happy National Doctor’s Day! Learn how to get a complimentary webcast on ‘Decoding Social Admissions’ as a token of our heartfelt appreciation! Click here to learn more →

CYBER WEEK IS HERE! Don’t miss your chance to get 20% off now until Dec. 2 with code CYBER24